IP Library Assignment 022191/0628
Patent Assignment
Reel/Frame 022191/0628

Document Re-Recorded to Correct Errors Ctonained in Property Number(S) 10/671,921, 11/807,956, 10/579,669 and 6,696,454. Document Previously Recorded on Reel 020206 Frame 0703. (Assignment of Assignor's Interest) or Nature of Conveyance.

Recorded: 2009-01-12 Pages: 7
Assignor
QUARK BIOTECH, INC.
Executed: 2007-06-01
Assignee
QUARK PHARMACEUTICALS, INC.
6501 DUMBARTON CIRCLE, FREMONT, CALIFORNIA, 94555
Covered Properties (5)
Inhibitors of Spermidine Synthase for the Treatment of Osteoarthritis and Cartilage Rehabilitation
Patent: 6,696,454 →
Application: 10/023,038 →
Publication: US 2002/0160978
Diagnosis and treatment of kidney fibrosis and other fibrotic diseases
Application: 10/579,662 →
Publication: US 2007/0004657
Mitotic kinesin-like protein-1, MKLP1, and uses thereof
Application: 10/671,921 →
Publication: US 2004/0115201
Therapeutic Modulation of the Fas Pathway
Patent: 7,749,977 →
Application: 11/586,021 →
Publication: US 2007/0042418
ISLR gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof
Application: 11/807,956 →
Publication: US 2007/0243186
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 30, 2004
From: EINAT, PAZ; DEISS, LOUIS; MAYA, RUTH
To: QUARK BIOTECH, INC.
Reel/Frame 015281/0625 →
Assignment of Assignor's Interest May 17, 2006
From: MOR, ORNA; FEINSTEIN, LENA; SHAPIRA, HAGIT
To: QUARK BIOTECH, INC.
Reel/Frame 017916/0013 →
Change of Name Dec 3, 2007
From: QUARK BIOTECH, INC.
To: QUARK PHARMACUTICALS, INC.
Reel/Frame 020206/0703 →